Alnylam Pharmaceuticals
ALNY
#585
Rank
ยฃ26.41 B
Marketcap
ยฃ205.78
Share price
1.81%
Change (1 day)
37.78%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Alnylam Pharmaceuticals (ALNY) - Cash on Hand

Cash on Hand as of June 2024 : ยฃ1.99 B

According to Alnylam Pharmaceuticals 's latest financial reports the company has ยฃ1.99 B in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Alnylam Pharmaceuticals - Cash on Hand chart (from 2003 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31ยฃ1.91 B5.66%
2022-12-31ยฃ1.81 B0.7%
2021-12-31ยฃ1.79 B31.07%
2020-12-31ยฃ1.37 B18.61%
2019-12-31ยฃ1.15 B36.24%
2018-12-31ยฃ0.84 B-32.07%
2017-12-31ยฃ1.25 B146.25%
2016-12-31ยฃ0.50 B-30.26%
2015-12-31ยฃ0.72 B62.75%
2014-12-31ยฃ0.44 B200.61%
2013-12-31ยฃ0.14 B96.02%
2012-12-31ยฃ75.94 M-19.37%
2011-12-31ยฃ94.19 M-37.84%
2010-12-31ยฃ0.15 B-13.56%
2009-12-31ยฃ0.17 B-41.27%
2008-12-31ยฃ0.29 B52.84%
2007-12-31ยฃ0.19 B76.07%
2006-12-31ยฃ0.11 B139.08%
2005-12-31ยฃ46.39 M93.25%
2004-12-31ยฃ24 M83.56%
2003-12-31ยฃ13.07 M35.49%
2002-12-31ยฃ9.65 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
ยฃ0.33 B-83.45%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ7.47 B 273.73%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ1.11 B-44.36%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ30.91 M-98.45%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ74.33 M-96.28%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ6.42 B 221.38%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
ยฃ5.55 B 177.53%๐Ÿ‡ซ๐Ÿ‡ท France
ยฃ1.72 B-13.97%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel